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Background: Intestinal barrier function is important for preserving health, as a compromised barrier allows antigen
entry and can induce inflammatory diseases. Probiotic bacteria can play a role in enhancing intestinal barrier
function; however, the mechanisms are not fully understood. Existing studies have focused on the ability of
probiotics to prevent alterations to tight junctions in disease models, and have been restricted to a few tight
junction bridging proteins. No studies have previously investigated the effect of probiotic bacteria on healthy
intestinal epithelial cell genes involved in the whole tight junction signalling pathway, including those encoding
for bridging, plaque and dual location tight junction proteins. Alteration of tight junction signalling in healthy
humans is a potential mechanism that could lead to the strengthening of the intestinal barrier, resulting in limiting
the ability of antigens to enter the body and potentially triggering undesirable immune responses.
Results: The effect of Lactobacillus plantarum MB452 on tight junction integrity was determined by measuring
trans-epithelial electrical resistance (TEER) across Caco-2 cell layers. L. plantarum MB452 caused a dose-dependent
TEER increase across Caco-2 cell monolayers compared to control medium. Gene expression was compared in
Caco-2 cells untreated or treated with L. plantarum MB452 for 10 hours. Caco-2 cell RNA was hybridised to human
oligonucleotide arrays. Data was analysed using linear models and differently expressed genes were examined
using pathway analysis tools. Nineteen tight junction-related genes had altered expression levels in response to L.
plantarum MB452 (modified-P < 0.05, fold-change > 1.2), including those encoding occludin and its associated
plaque proteins that anchor it to the cytoskeleton. L. plantarum MB452 also caused changes in tubulin and
proteasome gene expression levels which may be linked to intestinal barrier function. Caco-2 tight junctions were
visualised by fluorescent microscopy of immuno-stained occludin, zona occludens (ZO)-1, ZO-2 and cingulin. Caco-
2 cells treated with L. plantarum MB452 had higher intensity fluorescence of each of the four tight junction
proteins compared to untreated controls.
Conclusions: This research indicates that enhancing the expression of genes involved in tight junction signalling is
a possible mechanism by which L. plantarum MB452 improves intestinal barrier function.
Background
The intestinal barrier is the largest interface between
man and the external environment, and the mainte-
nance of its integrity has an important role in preserving
health. When intestinal barrier function is compromised,
it can become “leaky” allowing pathogens and toxins to
enter the body. The function of the intestinal barrier is
compromised in human conditions such as Inflamma-
tory Bowel Diseases (Crohn’s Disease and Ulcerative
Colitis) [1], Irritable Bowel Syndrome [2] and some
kinds of food-borne infections [3]. Moreover, intestinal
barrier function can be temporarily impaired during
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aging [5]. In addition, increased intestinal permeability
can also result in pathological changes in distant organs
and tissues, which can lead to further complications in
susceptible individuals such as asthma [6], chronic heart
failure [7], type-1-diabetes [8], chronic fatigue syndrome
[9] and depression [10].
A critical component of the intestinal barrier is the
intercellular junction complexes between adjacent
intestinal epithelial cells which form a semi-permeable
diffusion barrier. These intercellular complexes consist
of tight junctions, adherens junctions, desmosomes and
gap junctions [11]. The tight junctions are the most api-
cal and are responsible for controlling the permeability
of the paracellular pathway. Tight junctions are formed
by protein dimers that span the space between adjacent
cell membranes. There are over 40 proteins with well
recognised roles in tight junction formation. These pro-
teins can be divided into three functional categories: 1)
bridge proteins which form a web between adjacent cell
membranes; 2) plaque proteins which anchor bridge
proteins to the actin cytoskeleton; and 3) dual location
proteins which are not continuously associated with the
tight junctions and also act as transcription factors.
The maintenance or enhancement of intestinal barrier
function is a beneficial property that some probiotic
bacteria exert. Some probiotics have been shown to
ameliorate intestinal permeability induced by pathogens
in vitro [12,13]; whereas, others probiotic bacteria have
been shown to enhance tight junction integrity between
intestinal epithelial cells that are not weakened [13-15].
Existing mechanistic studies have focused on the ability
of probiotics to prevent alterations to few tight junction
bridging proteins in disease models, e.g. the effect of
VSL#3 on dextran sodium sulphate-induced colitis in
mice [16] and the effect of Lactobacillus plantarum
CGMCC 1258 on Enteroinvasive E. coli ATCC 43893
(serotype O124:NM)-induced barrier disruption in vitro
[17]. The effect of probiotics on tight junction proteins
in a healthy intestinal barrier have not been reported,
nor the effect of probiotic bacteria on epithelial cell
genes involved in the whole tight junction signalling
pathway, including those encoding for bridging, plaque
and dual location tight junction proteins. Alteration of
tight junction signalling in healthy humans is a potential
mechanism that could lead to the strengthening of the
intestinal barrier, resulting in limiting the ability of anti-
gens to enter the body and potentially triggering unde-
sirable immune responses.
The hypothesis of this research was that probiotic bac-
teria that increase intestinal barrier function achieve
this, partly, by increasing the expression of the genes
involved in tight junction signalling in healthy intestinal
epithelial cells. L. plantarum M B 4 5 2i s o l a t e df r o mt h e
probiotic product VSL#3 was chosen as the test bacter-
ium because it has a robust, repeatable, positive effect
tight junction integrity, as measured by the trans-epithe-
lial electrical resistance (TEER) in vitro (unpublished
results). VLS#3, which is a mixture of eight bacteria
including L. plantarum MB452, has previously been
reported to enhance tight junction integrity in vitro [18],
reduce colitis in rodent models [19,20] and improve
human intestinal health [21-23]. The effect of L. plan-
tarum MB452 on intestinal epithelial cells was investi-
gated in vitro using human colon cancer cells (Caco-2
cells), a commonly used model of the intestinal epithe-
lium that spontaneously form tight junctions between
adjacent cells, and trans-epithelial electrical resistance
assays, whole genome microarray analysis, and fluores-
cent microscopy of tight junction proteins.
Results
Effect of L. plantarum MB452 on TEER was dose-
dependent
The ability of L. plantarum MB452 to increase intestinal
barrier function was investigated by determining the
effect on TEER using different concentrations of L.
plantarum MB452 (Figure 1). At an OD600 nm of 0.3 (7
×1 0
7 CFU/mL) L. plantarum MB452 did not cause an
increase in TEER compared to the untreated controls.
At an OD600 nm of 0.6 (1.8 × 10
8 CFU/mL) L. plan-
tarum MB452 caused an increase in TEER of 15-20%
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Figure 1 Change in trans-epithelial electrical resistance (TEER)
across confluent Caco-2 monolayers (5 days old) over time in
the presence of different optical densities of L. plantarum
MB452. The change in TEER is the percentage change compared to
the initial TEER for each monolayer. The values plotted are the
means for four monolayers and the error bars show the SEM. OD =
the starting optical density of the L. plantarum cultures at 600 nm.
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8 CFU/mL) L. plantarum
MB452 caused an increase in TEER of 42-51% com-
pared to the untreated controls from 4 to 10 hours. The
effect of L. plantarum MB452 on TEER was 19-27%
higher at an OD600 nm of 0.9 compared to OD600 nmof
0.6 (P < 0.05 from 4 to 8 hours). Similarly, the effect of
L. plantarum MB452 on TEER was 23-33% higher at an
OD600 nm of 0.6 compared to OD600 nm of 0.3 (P < 0.05
from 4 to 8 hours).
The drop in TEER for all treatments between 0 and 2
hours observed in all assays was likely due to the Caco-
2 cell monolayers being disturbed by the change in
media during the sample addition after the initial read-
ings. The increase in TEER over time for the control
Caco-2 cells was likely due to an increase in nutrient
availability after the fresh media was added at the begin-
ning of the experiment. The increases in TEER caused
by L. plantarum MB452 were additional to those
observed with fresh media.
L. plantarum MB452 was also able to increase the
TEER by 20 at 2 hours to 64% at 10 hours across differ-
entiated Caco-2 cells (18 days old; Figure 2) in the same
manner as for confluent, undifferentiated cells (5 days
old; Figure 1). A differentiated, polarised Caco-2 cell
monolayer better represents the human intestinal barrier
than confluent undifferentiated Caco-2 cells. The tight
junctions between the differentiated Caco-2s were better
formed than the undifferentiated Caco-2s (higher initial
TEER readings), were less affected by the media addition
(no initial drop in TEER) and had less variation between
replicates (lower SEM values).
L. plantarum MB452 altered the expression of genes
involved tight junction formation
The ability of L. plantarum MB452 to alter gene expres-
sion in intestinal epithelial cells was measured using glo-
bal gene expression analysis. The analysis indicated that
1,181 Caco-2 cell genes were differentially expressed
(fold change > 1.2, modified-P < 0.05) when co-cultured
with L. plantarum MB452; the expression levels of 554
genes were increased and 627 genes were decreased. The
relatively low fold-change cut-off of 1.2 was selected
because the comparison was between untreated healthy
cells and healthy cells treated with potential beneficial
bacteria so large differences (as seen when comparing
healthy cells to a disease model) were not expected. The
ten Ingenuity Pathway Analysis (IPA) functional groups
with the most differentially expressed genes and the
Gene Ontology categories with the lowest P-values are
summarised in Additional File 1 Tables S1 and S2.
Of the genes that were differentially expressed in
response to L. plantarum MB452, 19 were involved in
tight junction formation (Table 1). Analysis of KEGG
pathways using EASE showed that the tight junction
pathway was one of four pathways that was enriched
with differentially expressed genes (P and global FDR <
0.05; Additional File 1 Table S3). The molecular interac-
tions between these genes were visualised in an IPA net-
work diagram (Figure 3). The nodes with the most
interactions are those that represent the genes for occlu-
din, ZO-1, ZO-2 and cingulin.
The expression levels of seven genes was also quanti-
fied using real-time PCR (qRT-PCR) and was compared
with the gene expression data obtained using microarray
analysis (Table 2). Of the 5 genes that had increased
expression in the microarray analysis, occludin and cin-
gulin were shown to have increased expression in
response to L. plantarum MB452 using qRT-PCR.
T h r e eo t h e rg e n e sw e r ed i f f e rentially expressed in the
microarray analysis but not in the qRT-PCR analysis.
The CLDN3 gene was not differentially expressed in the
microarray or qRT-PCR analyses. The GJA7 gene had
decreased expression in the microarray analysis (fold
change -1.39) and increased expression in the qRT-PCR
analysis (fold change 3.08). The variation between the
gene expression results obtained between the two tech-
niques is likely due to the fact that the qRT-PCR probes
used did not recognise the same transcripts as the
microarray probes, which is the most common reason
for discrepancies between results of the two methods. It
has been shown that when qRT-PCR and microarray
probes recognise the same transcripts there is an accor-
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Figure 2 Change in trans-epithelial electrical resistance (TEER)
across differentiated Caco-2 monolayers (18 days old) in the
presence of L. plantarum MB452 (OD600 nm 0.9). The change in
TEER is the percentage change compared to the initial TEER for
each monolayer. The values plotted are the means for four
monolayers and the error bars show the SEM.
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same transcripts there is an accordance of only 41%
[24]. These data indicated an accordance for 43% of the
genes (3/7 genes) using the two methods.
L. plantarum MB452 altered the expression of other tight
junction associated genes
Eight genes encoding for cytoskeleton tubulin proteins
had decreased expression levels (fold change -1.20 to
-1.45) in Caco-2 cells treated with L. plantarum MB452
(Table 3). Similarly, seven genes encoding for protein
degrading proteasomes had decreased expression levels
(fold change -1.21 to -1.28) in Caco-2 cells treated with
L. plantarum MB452 (Table 3).
L. plantarum MB452 visually increased the abundance of
tight junction proteins
Using fluorescent microscopy the intensity of the
immuno-stained ZO-1, ZO-2 occludin and cingulin
proteins appeared higher in the Caco-2 cells treated
with L. plantarum MB452 than in the untreated con-
trols (Figure 4). This indicated that the changes in gene
expression observed were supported by changes in tight
junction-associated protein intensity.
Discussion
As hypothesised, this study showed that L. plantarum
MB452 altered the expression levels of tight junction-
related genes in healthy intestinal epithelial cells. Of the
tight junction bridging proteins, occludin mRNA abun-
d a n c ew a sh i g h e ri nt h ep r e s e n c eo fL. plantarum
MB452. The over-expression of the occludin protein has
been linked to increased TEER [25], and based on the
findings of this study, increased occludin gene expres-
sion may contribute to the ability of L. plantarum
MB452 to enhance tight junction integrity. In support of
this, genes encoding for the occludin-associated plaque
proteins, ZO-1 and ZO-2 and cingulin, also had
Table 1 Caco-2 cell genes involved in intracellular junction complex formation that were differentially expressed in
the microarray analysis after co-culturing with L. plantarum MB452 (OD600 nm 0.9) for 10 hours
Gene Name Symbol Refseq ID Fold
Change
Moderated Description of role in relation to tight junctions
occludin OCLN NM_002538 1.39 0.004 tight junction bridging protein
vascular endothelial
growth factor A
VEGFA NM_001025366 1.39 0.002 cytokine that indirectly regulates tight junction formation and
strengthening
actin beta ACTB NM_001101 1.33 0.005 structural constituent of cytoskeleton








ACTC1 NM_005159 1.25 0.015 structural constituent of cytoskeleton
itchy homolog E3
ubiquitin protein ligase
ITCH NM_031483 1.25 0.011 ubiquitin-ligase molecule that regulates occludin degradation
junction plakoglobin JUP NM_002230 1.24 0.010 major cytoplasmic protein that forms a complex with cadherins
CNKSR family member 3 CNKSR3 NM_173515 1.24 0.006 tight junction plaque protein associated with JAMs
snail homolog 1 SNAI1 NM_005985 1.24 0.033 intracellular component that indirectly inhibits occuldin production
hepatocyte nuclear
factor 4 alpha
HNF4A NM_178849 1.24 0.021 transcription regulator that acts on occuldin
zona occludens 1 (tight
junction protein 1)
ZO-1 NM_003257 1.23 0.013 tight junction plaque protein associated with occludin, JAMs and
claudins
zona occludens 2 (tight
junction protein 2)
ZO-2 NM_004817 1.23 0.054 tight junction plaque protein associated with occludin and claudins
that acts as a guanylate kinase and also found in the nucleus
CD2-associated protein CD2AP NM_012120 1.22 0.012 scaffolding molecule that regulates the actin cytoskeleton
vinculin VCL NM_003373 1.22 0.027 cytoskeletal protein
membrane associated
guanylate kinase 3
MAGI-3 NM_152900 1.21 0.044 tight junction plaque protein a and guanylate kinase
membrane protein,
palmitoylated 5
MPP5 NM_022474 1.20 0.014 tight junction plaque protein associated with claudins and guanylate




CPSF2 NM_017437 -1.22 0.022 transcription regulator that decreases tight junction stability
cyclin-dependent
kinase 4
CDK4 NM_000075 -1.30 0.011 transcription regulator that decreases tight junction stability
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tarum MB452. The zonula occludens bind to the cyto-
plasmic end of occludin and form the scaffolding to link
occludin to the actin cytoskeleton [26]. The increased
expression levels of the occludin, ZO-1, ZO-2 and cin-
gulin genes appeared to correlate with increased inten-
sity of their proteins as indicated by the fluorescent
microscopy images.
In contrast, other genes that had increased transcript
levels in the presence of L. plantarum MB452 are
known to be involved in tight junction disassembly. The
gene encoding ITCH, an ubiquitin-ligase molecule, had
increased expression levels in the presence of L.
plantarum MB452; however, the ITCH protein is
known to contribute to the degradation of occludin
[27]. The increased expression of the ITCH gene may
lead to an increase in the turnover of occludin protein
Figure 3 Network of genes involved in tight junction formation that were differentially expressed by Caco-2 cells after being co-
cultured with L. plantarum MB452 (OD600 nm 0.9) for 10 hours. Genes are represented as nodes and the biological relationship between
two nodes is represented as an edge. All edges are supported by at least one reference from the literature. Red and green colored nodes
indicate genes that have increased or decreased expression, respectively, in response to L. plantarum MB452. The colors of the gene names
indicate the role the encoded proteins in relation to tight junctions.
Table 2 Comparison between microarray and qRT-PCR
analysis of Caco-2 cells genes after co-culturing with L.
plantarum MB452 (OD600 nm 0.9) for 10 hours

















1 Modified P-value < 0.05
2 P-value < 0.05
Table 3 Caco-2 cell tubulin and proteasome genes that
were differentially expressed (modified-P < 0.05) in the
microarray analysis after co-culturing with L. plantarum
MB452 (OD600 nm 0.9) for 10 hours
Gene Name Symbol Refseq ID Fold
Change
tubulin, alpha 1b TUBA1B NM_006082 -1.45
tubulin, alpha 1c TUBA1C NM_032704 -1.35
tubulin, alpha 3d TUBA3D NM_080386 -1.22
tubulin, alpha 4a TUBA4A NM_006000 -1.27
tubulin, beta TUBB NM_178014 -1.20
tubulin, beta 3 TUBB3 NM_006086 -1.20
tubulin, beta 6 TUBB6 NM_032525 -1.30
tubulin, beta 2c TUBB2C NM_006088 -1.35
proteasome, alpha subunit, 5 PSMA4 NM_002789 -1.24
proteasome, beta subunit, 1 PSMB1 NM_002793 -1.21
proteasome, beta subunit, 6 PSMB6 NM_002798 -1.22
proteasome, beta subunit, 7 PSMB7 NM_002799 -1.28
proteasome, 26 s subunit, 5 PSMC5 NM_002805 -1.24
proteasome, 26 s subunit non-
ATPase, 12
PSMD12 NM_002816 -1.25
proteasome, activator subunit, 2 PSME2 NM_002818 -1.24
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Page 5 of 11and, therefore, may have contributed to the increased
occludin mRNA noted in this data. The gene encoding
the SNAI1 protein also had increased expression in the
presence of L. plantarum MB452; however, the SNAI1
protein is known to bind to occludin and claudin genes
promoters suppressing their expression [28]. Although
these two genes, ITCH and SNAI1, have been linked to
tight junction disassembly, 17 out of the 19 tight junc-
tion-related genes with increased expression levels in








Figure 4 Fluorescent microscopy images of immuno-stained tight junction proteins of confluent Caco-2 cells (6 days old) untreated or
treated with L. plantarum MB452 (OD600 nm 0.9) for 8 hours. Treatments were carried out in quadruplicate and the images shown are
typical. ZO-1: zonula occluden 1; ZO-2 zonula occluden 2; OCLN: occludin; CGN: cingulin.
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Page 6 of 11to tight junction stability; therefore, the cumulative
effect would most likely be enhanced intestinal barrier
function.
The ‘tightness’ of tight junctions is commonly thought
to be, at least partly, due to claudins, which are a set of
bridging proteins; however, none of the claudin genes
were differentially expressed in response to L. plan-
tarum MB452. Decreases in the abundance of claudin-2,
-3 and -4 proteins (measured using western blotting)
have been associated with a decrease in TEER [29].
Another study showed that a decrease in TEER was
associated with altered cellular localisation of claudin-1
and -5, but not altered abundance [30], so it is possible
that L. plantarum MB452 may have altered the distribu-
tion of claudin proteins without changing gene expres-
sion and/or protein abundance.
The results of this study showed that L. plantarum
MB452 enhanced the expression of 19 genes involved in
the tight junction signalling pathway in healthy cells. A
previous study showed that L. plantarum CGMCC 1258
is able to protect against the disruption of four tight
junction proteins caused by Enteroinvasive E. coli ATCC
43893 (serotype O124:NM) [17]. However, another
study looking at the effect of L. plantarum
ATCC202195 on the expression of genes in Caco-2 cells
challenged with Enteroinvasive E. coli ATCC43893 (ser-
otype O124:NM) did not report any changes in tight
junction gene expression [31]. This suggests that the L.
plantarum protection against tight junction disruption
was not due to it altering host gene expression, and was
likely due to it inhibiting the action of the pathogen in
that study.
The ability to enhance the expression of tight junc-
tion-related genes is not common to all L. plantarum
strains. In addition to the study that showed that L.
plantarum ATCC202195 nullifies changes in Caco-2 cell
gene expression induced by Enteroinvasive E. coli
ATCC43893 (serotype O124:NM) [31], other published
studies investigating whole genome expression in
response to L. plantarum have shown that, L. plan-
tarum WCFSI induces increased expression of genes
involved in lipid metabolism and cellular growth and
development in healthy human duodenum [32] and L.
plantarum (strain not given) alters the NF-Bp a t h w a y
to limit inflammatory responses in healthy human duo-
denum [33]. However, in these published studies only a
few tight junction-related genes had altered expression
levels when exposed to L. plantarum, for example
increased expression of the ZO-2 gene, so they are unli-
kely to contribute to changes in tight junction integrity,
compared to the changes in 19 tight junction genes
induced by L. plantarum MB452 reported in this study.
This is not surprising since strains of L. plantarum can
have differing effects on intestinal barrier function in
vitro, from neutral (cause no increase in TEER) to bene-
ficial (cause substantial increase in TEER; unpublished
results), and thus, it is likely that different strains may
also have different effects on epithelial cell gene
expression.
The observed increase in intestinal barrier function
induced by L. plantarum MB452 may also be, at least
partly, due to changes in intestinal epithelial cell gene
expression that have an indirect effect on tight junction
stability. Eight genes encoding for tubulins had lower
expression levels in response to L. plantarum MB452. A
high turnover in tubulin synthesis has been linked to
the disassembly of tight junctions [34]; thus, the reduced
expression levels of these genes may account for the
positive effect of L. plantarum MB452 on intestinal bar-
rier function. Similarly, seven genes encoding for protea-
some subunits had lower mRNA abundance in the
presence of L. plantarum MB452. Proteasomes, which
are large protein complexes responsible for breaking
down surplus or damaged proteins, have previously
been linked to tight junction degradation, and protea-
some inhibitors can prevent degradation of occludin
[35] and ZO-2 [36]. The reduction in proteasome gene
expression induced by L. plantarum MB452 may be an
additional mechanism by which tight junction integrity
is enhanced.
Several of the tight junction-related genes with altered
expression induced by L. plantarum MB452 may also be
involved in reducing cell proliferation. For example, ZO-
1, which had increased gene expression in the presence
of L. plantarum MB452, is a ‘dual location protein’
involved in the regulation of cell proliferation. The ZO-
1 protein binds to the CSDA protein (also known as
ZONAB) and sequesters it to tight junctions, and
removal of the CSDA protein from nucleus in this way
r e s u l t si nar e d u c t i o ni nt h eC D K 4p r o t e i n[ 3 7 ] .T h e r e -
fore, an increase in ZO-1 gene expression may lead to a
decrease in CDK4 gene expression as seen here (Figure
3), which highlights the link between the formation of
tight junctions and a reduction in cell proliferation [37].
Additionally, L. plantarum MB452 reduced the expres-
sion of the CPSF2 gene, which encodes a protein which
is part of the CSTF-CPSF-SYMPK complex, that regu-
lates cell-cycle related gene expression and promotes
cell proliferation [38]. Together with the decreased
expression of tubulin genes, these effects of L. plan-
tarum M B 4 5 2o nt h eZ O - 1 ,C D K 4a n dC P S F 2g e n e s
may lead to decreased cell proliferation and contribute
to the reported anti-proliferative effect of the VSL#3
product [39].
L. plantarum MB452 did not alter the expression
levels of other genes and pathways that have been
affected by some probiotic bacteria, such as the NF-B
pathway [33], PPARg [40,41], innate immune response
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Page 7 of 11pathway [42], or human b defensin-2 [43]. This indicates
that, unlike some other probiotic bacteria, L. plantarum
MB452 does not seem to exert its beneficial effect by
regulating host immune responses in healthy intestinal
cells.
In this study using L. plantarum MB452 alone, only
certain effects previously associated with VSL#3 were
observed. VSL#3 is a mixture of L. plantarum, L. casei,
L. acidophilus, L. delbrueckii subspecies bulgaricus, B.
l o n g u m ,B .b r e v e ,B .i n f a n t i sand Streptococcus thermo-
philus, and is likely that each bacterial species has a
range of effects. A previous study indicated that of the
bacterial strains present in VSL#3, the culture superna-
tant of B. infantis was associated with the greatest
increase in TEER across Caco-2 cells compared to
untreated controls [15]. Of the VSL#3 lactobacilli, L.
plantarum MB452 produced the supernatant with the
greatest effect of TEER, which is in agreement with pre-
vious work that showed the beneficial effects of L. plan-
tarum MB452 supernatant [44]. Other studies indicated
that the anti-inflammatory effects of VSL#3 are, at least
partially, due to VSL#3 bifidobacteria decreasing the
abundance of the pro-inflammatory cytokine IL-8 [45]
and L. casei in VSL#3 reducing the abundance the pro-
inflammatory cytokine interferon gamma-induced pro-
tein 10 [46]. The genes encoding for these cytokines
were not altered in response to L. plantarum MB452 in
the present study.
Conclusions
The data presented in this study shows that a probiotic,
L. plantarum MB452, enhanced intestinal barrier func-
tion by affecting the expression of genes in the tight
junction signalling pathway in health intestinal epithelial
cells, in particular the genes encoding occludin and its
associated plaque proteins, ZO-1, ZO-2 and cingulin.
Further studies will investigate the function of these key
genes and evaluate their role in L. plantarum MB452
mediated changes in intestinal barrier function. These
results also highlight that changes in intestinal barrier
function may also be linked to changes in tubulin and/
or proteasome gene expression. Further targeted studies
will investigate whether these gene expression changes
are important in the observed enhanced intestinal bar-
rier function, and, if so, the mechanisms involved. The
long-term aim is to understand the way in which bac-
teria increase tight junction integrity in order to develop
probiotic foods that enhance intestinal barrier function
and therefore improve human wellness.
Methods
Bacterial strains
Lactobacillus plantarum MB452 [47] was isolated from
VSL#3 (Orphan Australia Pty Ltd, Berwick, Australia). A
sachet of VSL#3 powder was suspended in 50 mL of
sterile water and the culture was streaked on MRS agar
plates (de Man, Rogosa and Sharpe Broth, Difco, Sparks,
USA) and incubated aerobically at 30°C, 37°C and 42°C
and anaerobically at 37°C. Colony morphologies were
recorded and sample colonies from each plate were sub-
cultured into Brain Heart Infusion broth (Difco, USA)
with 30% glycerol for storage at -85°C. As described in
Additional File 2, colonies with similar morphology
were compared using pulse-field gel electrophoresis and
representatives of each profile were identified based on
their 16 s rRNA sequences.
Mammalian cell culture
Caco-2 cell (HTB-37; ATCC) stock cultures were grown
in T75 flasks in M199 tissue culture medium with 10%
foetal bovine serum (GIBCO, Invitrogen Corporation,
Auckland, NZ), 1% non-essential amino acids (MEM
non-essential amino acids 100× solution, Sigma-Aldrich,
St Louis, USA) and 1% penicillin-streptomycin (10,000
units penicillin G sodium salt and 10000 g streptomycin
sulphate in 0.85% saline, GIBCO, Invitrogen Corpora-
tion, Auckland, NZ) at 37 C in 5% CO2. The media was
replaced every 3 to 4 days and the cells were subcul-
tured weekly at a ratio of 1:3. Caco-2 cells with a pas-
sage number of 30 to 35 were used for all experiments.
Trans-epithelial electrical resistance assay
Caco-2 cells were seeded onto 14 mm collagen mem-
brane inserts (Cellagen™ Discs CD-24, MP Biomedicals,
O h i o ,U S A )a tad e n s i t yo f1 0
5 cells/insert. Each insert
was placed in a well in a 12-well plate with 1 mL of
media in the bottom and 250 µL media in the top. The
media was replaced every 2 to 3 days. Confluent Caco-2
monolayers (5 days old) were used for the majority of
the TEER experiments; except for the TEER experiment
done in parallel with the gene expression experiment
where differentiated Caco-2 monolayers were used (18
days old). All Caco-2 monolayers had initial TEER
values of greater than 300 ohms.cm
2.T h eC a c o - 2
monolayers were prepared the day before the TEER
assay by removing the media, washing three times with
PBS and adding M199 with 1% non-essential amino
acids (without foetal bovine serum and penicillin-strep-
tomycin) to ensure growth of the bacterial cells. To pre-
pare the bacteria for the TEER assay, an overnight
culture of bacterial cells (MRS broth, 37°C, 5% CO2)
were collected by centrifugation (12,000 rpm for 5 min-
utes in a micro centrifuge), washed in phosphate buf-
fered saline (PBS, pH 7.2), and suspended in M199 with
1% non-essential amino acids to the required optical
density at 600 nm. After the initial resistance readings
were taken on the day of the experiment, the media was
removed from the top of the Caco-2 monolayers and
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the spent media was replaced with fresh media (M199
and 1% non-essential amino acids). Each treatment was
performed in quadruplicate and each assay was repeated
three times.
Every two hours, each insert was lifted into an elec-
trode chamber (ENDOHM-12 tissue culture chamber,
World Precision Instruments, Florida, USA) using sterile
tweezers and the resistance was measured using a vol-
tohmmeter (EVOM Epithelial Tissue Voltohmmeter,
World Precision Instruments, Florida, USA). The TEER
was calculated from the resistance using the formula:
TEER (Ω cm
2) = (resistance (Ω) – background resis-
tance (Ω)) × membrane area (cm
2), where the back-
ground resistance was 14 and the membrane area was
1.54 cm
2. The change in TEER for each insert was cal-
culated using the following formula: change in TEER
(%) = TEER (Ω cm
2)/initial TEER (Ω.cm
2)-1 0 0( % ) .
The mean change in TEER was plotted against time,
with the error bars showing the SEM. Treatments were
compared in GenStat (Version 11.1.0.1575) using resi-
dual maximum likelihood analysis with an unstructured
covariance model to take account of the repeated mea-
sures. Statistical differences between treatments were
declared at a probability less than 0.05 whilst a probabil-
ity between 0.05 and 0.1 was considered to represent a
trend.
Gene expression analysis
Caco-2 cells were seeded into all wells in 6-well plates at
ad e n s i t yo f3×1 0
5 cells/well. The media was replaced
every 3-4 days and the Caco-2 monolayers were grown
for 18 days to allow them to differentiate. Six wells were
treated with L. plantarum MB452 (OD 600 nm of 0.9)
suspended in cell culture media (M199 and 1% non-
essential amino acids) and six wells were treated with
control media. After 10 hours of exposure (37°C, 5%
CO2)t h et r e a t m e n ts o l u t i o n sw e r er e m o v e da n dt h e
monolayers were rinsed with PBS.
The total RNA was extracted from the Caco-2 cells
using TRIzol, (Invitrogen, Auckland, New Zealand) and
purified using RNeasy mini columns (QIAGEN, San
Diego, CA, USA). An equal amount of RNA from three
wells of the same treatment was pooled together to
yield enough RNA for the gene expression analysis
(microarray and qRT-PCR); two control pools and two
pools treated with L. plantarum MB452. Equal amounts
of RNA from all 12 wells were pooled together to make
the reference RNA sample. A similar experimental
design previously gave biologically relevant results
[48,49]. RNA samples were labelled, amplified and
hybridised to Agilent Technologies 44 k whole human
genome oligonucleotide arrays (G4112A) according to
the manufacturer’s instructions. The Limma package in
Bioconductor was used to analyse the microarray data
[50]. Genes with a fold change greater than 1.2 and a
modified p-value less than 0.05 were considered differ-
entially expressed. Differentially expressed genes were
clustered into functional groups and pathways using
Ingenuity Pathway Analysis (IPA version 7.1; Ingenuity
Systems Inc., Redwood City, CA, USA), and Gene
Ontology categories and KEGG pathways using EASE
(version 2.0)[51]. The raw microarray data have been
deposited in the NCBI Gene Expression Omnibus under
the GEO accession number GSE18372. Full details of
the methods are given in Additional File 3.
The expression of tight junction-related genes differ-
entially expressed from the microarray analysis was con-
firmed using qRT-PCR. The expression of seven target
genes relative to three reference genes was assessed
using the standard curve method. The reference genes
(GAPD, SDHA and YWHAZ) were chosen based on the
findings of Vandesompele et al [52] and their log ratios
i nt h em i c r o a r r a yd a t a( c l o s et o1 ;n o td i f f e r e n t i a l l y
expressed). Five target genes (ZO-1, ZO-2, OCLN, CGN
and ACTB) were chosen from the tight junction-related
genes that were differentially expressed (all up-regu-
lated) in the microarray analysis. The two other target
genes, GJA7 and CLDN3, were chosen to be included
because they were down-regulated and not differentially
expressed, respectively, in the microarray analysis. The
analysis was carried out as described in Additional File
3 and the data was analysed using Relative Expression
Software Tool 2008 (version 2.0.7) with efficiency cor-
rection [53].
Fluorescent microscopy
Caco-2 cells were grown on Lab Tek II Chamber Slides
with Permanox™ coating (Nalge Nunc International
Corp, Naperville, IL, USA) for 6 days until confluent.
Caco-2 cells were treated with L. plantarum MB452
(OD 600 nm 0.9) or control media for 8 hours (n = 4
per treatment per antibody). After treatment, Caco-2
cells were rinsed twice with PBS, fixed in either 4% (w/
v) paraformaldehyde for 20 minutes (for CGN and ZO-
1) or ice cold 70% ethanol (for ZO-2 and OCLN),
quenched with 50 mM NH4Cl (in PBS) for 15 minutes,
and blocked with blocking solution (2% (v/v) foetal
bovine serum, 1% sheep serum albumin, 0.1% Triton X-
100, 0.05% Tween 20 in PBS, pH 7.2) for 20 minutes.
Caco-2 cells were then immuno-stained with the pri-
mary antibodies (2.5 µg/mL rabbit anti-ZO-1, 1.25 µg/
mL rabbit anti-ZO-2, 2.5 µg/mL rabbit anti-occludin, 1
µg/mL rabbit anti-cingulin; Zymed, Invitrogen, NZ) in
blocking solution for 1 hour, followed by a PBS wash
(0.1% Triton X-100, 0.05% Tween 20 in PBS) to reduce
non-specific staining, and the secondary antibody, Alexa
Fluor 488 goat anti-rabbit IgG (5 µg/mL for ZO-2, 10
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1 hour. The slides were imaged with a fluorescent
microscope (Leica DM2500 microscope, Leica DFC420C
camera) with the following settings: exposure 1.1 ms,
saturation 2.25, gamma 1.52, gain 8.4× and magnifica-
tion 40×. The images were viewed using LAS Image
Overlay software (Leica Application Suite v1.8.2).
Additional material
Additional file 1: Summary of microarray analysis. Contains Tables S1,
S2 and S3 which summarise the differentially expressed IPA Functional
Groups, Gene Ontology categories and KEGG pathways, respectively.
Additional file 2: Identification of L. plantarum MB 452 from VSL#3.
Describes the Pulse-field gel electrophoresis and 16 s sequencing
methods used to identify L. plantarum MB 452.
Additional file 3: Analysis of gene expression of Caco-2 cells treated
with L. plantarum MB452. Describes the microarray analysis and qRT-
PCR analysis. Include Table S4 showing the qRT-PCR primers.
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